These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1324320)

  • 1. 4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation.
    Calvino R; Fruttero R; Ghigo D; Bosia A; Pescarmona GP; Gasco A
    J Med Chem; 1992 Aug; 35(17):3296-300. PubMed ID: 1324320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacochemistry of the furoxan ring: recent developments.
    Calvino R; Di Stilo A; Fruttero R; Gasco AM; Sorba G; Gasco A
    Farmaco; 1993 Feb; 48(2):321-34. PubMed ID: 8388218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets.
    Ghigo D; Heller R; Calvino R; Alessio P; Fruttero R; Gasco A; Bosia A; Pescarmona G
    Biochem Pharmacol; 1992 Mar; 43(6):1281-8. PubMed ID: 1348617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor.
    Civelli M; Caruso P; Giossi M; Bergamaschi M; Razzetti R; Bongrani S; Gasco A
    Eur J Pharmacol; 1994 Apr; 255(1-3):17-24. PubMed ID: 7517880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.
    Turnbull CM; Cena C; Fruttero R; Gasco A; Rossi AG; Megson IL
    Br J Pharmacol; 2006 Jun; 148(4):517-26. PubMed ID: 16702997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No-mimetic furoxans: arylsulphonylfuroxans and related compounds.
    Ferioli R; Fazzini A; Folco GC; Fruttero R; Calvino R; Gasco A; Bongrani S; Civelli M
    Pharmacol Res; 1993; 28(3):203-12. PubMed ID: 8108310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.
    Ferioli R; Folco GC; Ferretti C; Gasco AM; Medana C; Fruttero R; Civelli M; Gasco A
    Br J Pharmacol; 1995 Feb; 114(4):816-20. PubMed ID: 7773542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.
    Lazzarato L; Cena C; Rolando B; Marini E; Lolli ML; Guglielmo S; Guaita E; Morini G; Coruzzi G; Fruttero R; Gasco A
    Bioorg Med Chem; 2011 Oct; 19(19):5852-60. PubMed ID: 21906954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
    Matsuoka I; Nakahata N; Nakanishi H
    Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
    Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
    Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.
    Civelli M; Giossi M; Caruso P; Razzetti R; Bergamaschi M; Bongrani S; Gasco A
    Br J Pharmacol; 1996 Jun; 118(4):923-8. PubMed ID: 8799563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of ibuprofen derivatives with reduced gastrotoxicity.
    Lolli ML; Cena C; Medana C; Lazzarato L; Morini G; Coruzzi G; Manarini S; Fruttero R; Gasco A
    J Med Chem; 2001 Oct; 44(21):3463-8. PubMed ID: 11585451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.
    Dutra LA; Guanaes JFO; Johmann N; Lopes Pires ME; Chin CM; Marcondes S; Dos Santos JL
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2450-2453. PubMed ID: 28400236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.
    Tsikas D; Ikic M; Tewes KS; Raida M; Frölich JC
    FEBS Lett; 1999 Jan; 442(2-3):162-6. PubMed ID: 9928994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents based on cyclooxygenase inhibition without ulcerogenesis. Evaluation and synthesis of 4,5-bis(4-methoxyphenyl)-2-substituted-thiazoles.
    Tanaka A; Sakai H; Motoyama Y; Ishikawa T; Takasugi H
    J Med Chem; 1994 Apr; 37(8):1189-99. PubMed ID: 8164261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimalarial activities of some furoxan sulfones and related furazans.
    Galli U; Lazzarato L; Bertinaria M; Sorba G; Gasco A; Parapini S; Taramelli D
    Eur J Med Chem; 2005 Dec; 40(12):1335-40. PubMed ID: 15979766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.